Cargando…

Risk Prediction of Major Adverse Cardiovascular Events Occurrence Within 6 Months After Coronary Revascularization: Machine Learning Study

BACKGROUND: As a major health hazard, the incidence of coronary heart disease has been increasing year by year. Although coronary revascularization, mainly percutaneous coronary intervention, has played an important role in the treatment of coronary heart disease, major adverse cardiovascular events...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jinwan, Wang, Shuai, Zhu, Mark Xuefang, Yang, Tao, Yin, Qingfeng, Hou, Ya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069286/ https://www.ncbi.nlm.nih.gov/pubmed/35442202 http://dx.doi.org/10.2196/33395

Ejemplares similares

Machine learning for the prediction of minor amputation in University of Texas grade 3 diabetic foot ulcers
por: Wang, Shiqi, et al.
Publicado: (2022)

Predictors for the Development of Major Adverse Limb Events after Percutaneous Revascularization—Gender-Related Characteristics
por: Comsa, Horatiu, et al.
Publicado: (2023)

Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial
por: Akrami, Mehdi, et al.
Publicado: (2021)

Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study
por: Kim, Mihui, et al.
Publicado: (2022)

Correlation between serum cartilage oligomeric matrix protein and major adverse cardiovascular events within 30 days in patients with acute coronary syndrome
por: Chen, Hao, et al.
Publicado: (2021)

The Burden of Short-term Major Adverse Cardiac Events and its Determinants after Emergency Percutaneous Coronary Revascularization: A Prospective Follow-up Study
por: Kumar, Rajesh, et al.
Publicado: (2022)

The burden of major adverse cardiac events in patients with coronary artery disease
por: Tsai, I-Ting, et al.
Publicado: (2017)

Association Between Wearable Device–Based Measures of Physical Frailty and Major Adverse Events Following Lower Extremity Revascularization
por: Najafi, Bijan, et al.
Publicado: (2020)

Associations of Modified Healthy Aging Index With Major Adverse Cardiac Events, Major Coronary Events, and Ischemic Heart Disease
por: Huang, Ninghao, et al.
Publicado: (2023)

Impact of pre-procedural diastolic blood pressure on major adverse cardiovascular events in non ST-segment elevation myocardial infarction patients following revascularization
por: Wang, Xiong, et al.
Publicado: (2023)

Clinical Nomogram to Predict Major Adverse Cardiac Events in Acute Myocardial Infarction Patients within 1 Year of Percutaneous Coronary Intervention
por: Pan, Defeng, et al.
Publicado: (2021)

Association of NFKB1 gene rs28362491 mutation with the occurrence of major adverse cardiovascular events
por: Luo, Jun-Yi, et al.
Publicado: (2022)

Correlation of myocardial perfusion defects on Stress MR perfusion study with occurrence major adverse cardiac events in patients with moderate coronary artery disease
por: Bannur, Mahesha
Publicado: (2015)

Analysis between high risk of myocardial infarction with non‐obstructive coronary artery disease in single center and occurrence of major adverse cardiovascular events
por: Kong, Meihong, et al.
Publicado: (2022)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
por: Chen, Zhihao, et al.
Publicado: (2018)

Utilization of interpretable machine learning model to forecast the risk of major adverse kidney events in elderly patients in critical care
por: Wang, Lin, et al.
Publicado: (2023)

Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes
por: Xie, Gaoqiang, et al.
Publicado: (2017)

Major adverse cardiac events and drug-coated balloon size in coronary interventions
por: Naguib, David, et al.
Publicado: (2018)

Correlation between monocyte to high-density lipoprotein ratio and major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
por: Yu, Rong, et al.
Publicado: (2021)

Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
por: Ikebe, So, et al.
Publicado: (2023)

Machine learning models for prediction of adverse events after percutaneous coronary intervention
por: Niimi, Nozomi, et al.
Publicado: (2022)

Stratification of coronary artery disease patients for revascularization procedure based on estimating adverse effects
por: Pölsterl, Sebastian, et al.
Publicado: (2015)

Myocardial revascularization at extremes – surgical revascularization in acute coronary syndrome
por: Kacar, S, et al.
Publicado: (2013)

On-pump beating heart coronary revascularization: Is it valid for emergency revascularization?
por: Aydin, Ahmet, et al.
Publicado: (2015)

Serum miR-497-5p serves as a diagnostic biomarker for acute coronary syndrome and predicts the occurrence of major adverse cardiovascular events after percutaneous coronary intervention
por: Chen, Tao, et al.
Publicado: (2022)

Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment
por: Sen, Sayan, et al.
Publicado: (2019)

Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome
por: Pavasini, Rita, et al.
Publicado: (2022)

Predictors of major adverse cardiac events following elective stenting of large coronary arteries
por: Aghajani, Hassan, et al.
Publicado: (2018)

Risk factors for major adverse cardiovascular events after the first acute coronary syndrome
por: Okkonen, Marjo, et al.
Publicado: (2021)

Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisation
por: Jung, Richard G, et al.
Publicado: (2022)

Coronary Revascularization in Patients With Cancer
por: Pushparaji, Bala, et al.
Publicado: (2023)

A highly predictive cardiac positron emission tomography (PET) risk score for 90-day and one-year major adverse cardiac events and revascularization
por: McCubrey, Raymond O., et al.
Publicado: (2022)

Machine learning prediction of postoperative major adverse cardiovascular events in geriatric patients: a prospective cohort study
por: Peng, Xiran, et al.
Publicado: (2022)

Comparison of conventional scoring systems to machine learning models for the prediction of major adverse cardiovascular events in patients undergoing coronary computed tomography angiography
por: Ghorashi, Seyyed Mojtaba, et al.
Publicado: (2022)

Circulating mir-199-3p screens the onset of type 2 diabetes mellitus and the complication of coronary heart disease and predicts the occurrence of major adverse cardiovascular events
por: Ruan, Renjie, et al.
Publicado: (2023)

Depressive symptoms and major adverse cardiovascular events: 12-month follow-up in patients undergoing angiography
por: Dadkhah-Tirani, Heidar, et al.
Publicado: (2020)

Comparison of coronary plaque, coronary artery calcification and major adverse cardiac events in Chinese outpatients with and without type 2 diabetes
por: Zhu, Lijie, et al.
Publicado: (2016)

Association of Lower Fractional Flow Reserve Values With Higher Risk of Adverse Cardiac Events for Lesions Deferred Revascularization Among Patients With Acute Coronary Syndrome
por: Masrani Mehta, Shriti, et al.
Publicado: (2015)

Occurrence and Impact of Gastrointestinal Bleeding and Major Adverse Cardiovascular Events during Sepsis: A 15-Year Observational Study
por: Hsieh, Ming-Shun, et al.
Publicado: (2020)

Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
por: Cai, Anping, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1a17s5t29p1v06f0dtsaf37hdq